[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
/in Acute Leukemia, Dendritic Cells, International PublicationsAllogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.
/in Dendritic Cells, Hypernephroma, International PublicationsCancer immunotherapy: a paradigm shift for prostate cancer treatment
/in Dendritic Cells, International Publications, Prostate CancerVelogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
/in International Publications, Newcastle Disease VirusSuccessful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
/in Dendritic Cells, Hyperthermia, International Publications, Ovarian CancerHyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
/in Colorectal Cancer, Hyperthermia, International PublicationsCurrent status of immunological approaches for the treatment of prostate cancer
/in International Publications, Prostate Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer